An immune-centric exploration of BRCA1 and BRCA2 germline mutation related breast and ovarian cancers
BRCA1/2 germline mutation related cancers are candidates for new immune therapeutic interventions. This study was a hypothesis generating exploration of genomic data collected at diagnosis for 19 patients. The...
20:197
BMC Cancer 2020
No hay comentarios:
Publicar un comentario